Corvus Pharmaceuticals stock price
코르버스 파머슈티컬스NASDAQ:CRVS · Nasdaq · Healthcare$10.74-1.47%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Corvus Pharmaceuticals last closed at $10.74 (-1.47%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -18.3×. Its overall grade ranks 220 of 741 stocks in Healthcare.
About this company
Corvus Pharmaceuticals last closed at $10.74 (-1.47%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A- · 220/741
Valuation grade A+
Related stocks
- AstraZenecaCompetitor
면역항암제·종양/염증 치료제 개발 영역에서 경쟁
- Merck & Co.Competitor
면역항암 및 항암제 시장의 대형 경쟁사
- Bristol Myers SquibbCompetitor
면역항암·항암 파이프라인 경쟁사
About Corvus Pharmaceuticals
- What technical signals does Corvus Pharmaceuticals (CRVS) have?
- Corvus Pharmaceuticals current technical signals: no active technical signal.
- Is Corvus Pharmaceuticals a cup-and-handle pattern?
- No. Corvus Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Corvus Pharmaceuticals?
- Market cap: $802.08M. Trailing 12 months PER: -18.3×. Latest quarter PBR: 4.40×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Corvus Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy